Pharmaceutical GMP Readiness in Australia
Australia's Therapeutic Goods Administration (TGA) regulates medicines under the Therapeutic Goods Act 1989.
In Short
- TGA is the federal regulator.
- Australian sites need a TGA manufacturing licence.
- Release for supply in Australia is performed by an authorised person under the sponsor/manufacturer's QMS — no statutory QP.
Australian GMP is the PIC/S Guide to GMP (PE 009, current version) plus annexes, adopted by reference. Domestic manufacturers need a manufacturing licence; overseas manufacturers supplying the Australian Register of Therapeutic Goods (ARTG) need a GMP Clearance (CV — Compliance Verification, MRA, or Desktop). TGA is a long-standing PIC/S member with an EU–AU MRA for human medicines. This guide covers the Australia layer over an ICH Q10 PQS.
Regulator and Legal Basis
TGA is the federal regulator. Statutes: Therapeutic Goods Act 1989; Therapeutic Goods Regulations 1990; Therapeutic Goods (Manufacturing Principles) Determination which adopts PIC/S PE 009 as Australian GMP.
More on regulator and Legal Basis
Sponsors (Australian-resident entities) list products on the ARTG.
Manufacturing Licence and GMP Clearance
Australian sites need a TGA manufacturing licence. Overseas manufacturers do not need an Australian licence but every overseas site referenced on an ARTG entry needs a GMP Clearance, granted via one of three pathways: MRA Clearance (using EU/EEA/UK/Swiss/Canadian GMP certificates under MRA), Compliance Verification Clearance (CV — TGA evaluates an inspection report and evidence), or, in narrow cases, Desktop Assessment for low risk.
Release model and distribution
Release for supply in Australia is performed by an authorised person under the sponsor/manufacturer's QMS — no statutory QP. Distribution follows the Australian Code of Good Wholesaling Practice (GWP) and state-level licensing.
More on release model and distribution
Serialization is not federally mandated.
Inspection Style and Common Findings
TGA inspections use PIC/S classifications (critical/major/other). Common findings: Annex 1 contamination control, data integrity (ALCOA+), validation lifecycle (Annex 15), and supplier qualification.
More on inspection Style and Common Findings
TGA publishes outcomes selectively and may suspend or cancel the manufacturing licence or ARTG entry.
A 90–180 day Australia readiness path
- Days 0–30
identify the sponsor, ARTG entries, and overseas sites needing GMP Clearance.
- Days 31–90
assemble MRA evidence (EU/UK/CH/CA certificates and inspection reports) or prepare a CV application.
- Days 91–180
apply for GMP Clearance; respond to TGA queries; ensure the Australian sponsor holds the technical file and release records.
Questions
Do we need a TGA inspection if we have an EU GMP certificate?
Generally no — the MRA Clearance pathway accepts current EU/EEA/UK/Swiss/Canadian GMP certificates for human medicines. TGA may still inspect for risk-based reasons or for product classes outside the MRA.
What is the difference between MRA Clearance and CV Clearance?
MRA Clearance leverages a current GMP certificate from an MRA partner authority. CV Clearance is used when no MRA applies — TGA evaluates an inspection report (often from a PIC/S partner) plus evidence. CV is slower and more document-intensive.
Does Australia have a QP?
No statutory QP. The licensed manufacturer's authorised person releases batches under PIC/S Part I; for overseas-manufactured product, the EU/UK QP certification is normally relied on via MRA.
Practical orientation, not legal advice. Rules differ by jurisdiction; your quality and compliance team decides what applies.
The Pharmaceutical Operations Guide
Right material. Right record. Released by a person.
- Who decides, and who may not
- Supplier to finished bulk
- Test, review, investigate
- Packs, serialisation and recall
Plus Evidence map and four worksheets.
Get the pharmaceutical guideWe ask for your name and email so we can handle this request. The full guide then opens on this site, ready to translate, print or save. Privacy policy. Practical orientation, not legal advice; your quality unit decides which rules apply.
UltimateFree guide
The Pharmaceutical Operations Guide
Right material. Right record. Released by a person.
Keep reading
Global Pharmaceutical GMP Readiness: Principles That Travel- Brazil Pharmaceutical GMP Readiness: ANVISA RDC 658/2022
Canada Drug GMP Readiness: Food and Drug Regulations Part C, Division 2
China Pharmaceutical GMP Readiness: NMPA and China GMP
EU GMP Guide: EudraLex Volume 4 Chapters, Annexes and Who Decides
GCC Pharmaceutical GMP Readiness: Saudi SFDA and UAE